Skip to main content
Clinical Trials/NCT02277782
NCT02277782
Terminated
Not Applicable

Intrathecal Hydromorphone for Labor Analgesia

Brigham and Women's Hospital1 site in 1 country21 target enrollmentSeptember 1, 2015

Overview

Phase
Not Applicable
Intervention
Hyperbaric bupivacaine
Conditions
Pregnancy
Sponsor
Brigham and Women's Hospital
Enrollment
21
Locations
1
Primary Endpoint
Effect on maternal temperature during labor
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

The objective of this study is to evaluate the effect of intrathecal hydromorphone on the duration of labor analgesia and the incidence of epidural-associated temperature increase in laboring parturients. We hypothesize that intrathecal administration of longer-acting hydromorphone will:

  1. Prolong the duration and improve the quality of analgesia in labor, and
  2. Decrease the incidence of epidural-associated temperature increase in labor.
Registry
clinicaltrials.gov
Start Date
September 1, 2015
End Date
December 31, 2019
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dominique Arce

Instructor of Anaesthesia

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients are eligible for enrollment if they are healthy, pregnant females between the ages of 18 and 45 years, primiparous, and at term gestation (≥ 37 weeks).

Exclusion Criteria

  • Patients with a Category II or III fetal heart rate tracing, a fetus with intrauterine growth restriction, prolonged rupture of membranes, recent diagnosis of infection of any cause, or in whom dural puncture is contraindicated will be excluded from the study.

Arms & Interventions

No Hydromorphone

1.7 mg bupivacaine + 17 mcg fentanyl + 0.05 ml of 0.9% normal saline.

Intervention: Hyperbaric bupivacaine

No Hydromorphone

1.7 mg bupivacaine + 17 mcg fentanyl + 0.05 ml of 0.9% normal saline.

Intervention: Fentanyl

Hydromorphone

1.7 mg bupivacaine + 17 mcg fentanyl + 50 mcg preservative-free hydromorphone (0.05 ml)

Intervention: Hydromorphone

Hydromorphone

1.7 mg bupivacaine + 17 mcg fentanyl + 50 mcg preservative-free hydromorphone (0.05 ml)

Intervention: Hyperbaric bupivacaine

Hydromorphone

1.7 mg bupivacaine + 17 mcg fentanyl + 50 mcg preservative-free hydromorphone (0.05 ml)

Intervention: Fentanyl

Outcomes

Primary Outcomes

Effect on maternal temperature during labor

Time Frame: 2 years

The primary outcome measure will be the incidence of maternal temperature increase, defined as an increase in maternal temperature by 1 degree celsius over the baseline temperature recorded prior to the onset of epidural analgesia.

Secondary Outcomes

  • Effect on efficacy of labor analgesia(2 years)

Study Sites (1)

Loading locations...

Similar Trials